CCF Releases New Video on Surgery for Neuroendocrine Tumors

Many doctors have historically considered surgery the first and best option for treating a neuroendocrine tumor (NET), when appropriate for their patients. But with all the treatments that have emerged over the past 10 years, as well as new perspectives on treating these tumors, is that still the case?

NET experts Dr. Alexandra Gangi, Dr. Rodney F. Pommier, and Dr. Mark A. Lewis weigh in on surgery’s role in the treatment process, including: which patients are ideal surgical candidates, when is surgery not an option, at what point in sequencing of treatments does surgery fall, and what new developments have occurred that make the chances of removing a NET through surgery more likely.

Dr. Lewis provides a unique perspective on surgery as an oncologist and NET patient who had the Whipple surgical procedure himself!

Print Friendly, PDF & Email